A Case of Intravitreal Bevacizumab Injection for the Treatment of Choroidal Neovascularization in Angioid Streaks
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A 56-year-old Korean woman presented with decreased visual acuity of the right eye. She had a history of two pho-todynamic therapy treatments for choroidal neovascularization (CNV) due to angioid streaks in her left eye with cen-tral scarring and low visual acuity. She was diagnosed with subfoveal CNV due to angioid streaks in her right eye and treated with six intravitreal bevacizumab (1.25 mg / 0.05 mL) injections over one year. Best corrected visual acuity improved from 20 / 125 at baseline to 20 / 50 at the final visit. The area of CNV had changed into a fibrotic scar by the final visit, and fluorescein angiography and indocyanine green angiography revealed no evidence of leakage. Optical coherence tomography showed that central macular thickness decreased from 311 μm at baseline to 203μm with complete resolution of subretinal and intraretinal fluid at the final visit. Intravitreal bevacizumab for CNV as-sociated with angioid streaks prevented the progression of disease and resulted in the improvement of visual acuity after one year of follow-up in our patient.
Abstract
A 56-year-old Korean woman presented with decreased visual acuity of the right eye. She had a history of two pho-todynamic therapy treatments for choroidal neovascularization (CNV) due to angioid streaks in her left eye with cen-tral scarring and low visual acuity. She was diagnosed with subfoveal CNV due to angioid streaks in her right eye and treated with six intravitreal bevacizumab (1.25 mg / 0.05 mL) injections over one year. Best corrected visual acuity improved from 20 / 125 at baseline to 20 / 50 at the final visit. The area of CNV had changed into a fibrotic scar by the final visit, and fluorescein angiography and indocyanine green angiography revealed no evidence of leakage. Optical coherence tomography showed that central macular thickness decreased from 311 μm at baseline to 203μm with complete resolution of subretinal and intraretinal fluid at the final visit. Intravitreal bevacizumab for CNV as-sociated with angioid streaks prevented the progression of disease and resulted in the improvement of visual acuity after one year of follow-up in our patient.
참고문헌 (19)
- Mansour AM, "Systemic associations of angioid streaks", Int Ophthalmol Clin, 31, pp.61~68 (1991)
- Piro PA, "Angioid streaks: natural history and visual progression. In: Management of retina vascular and macular disorders", pp.136~139 (1983), Williams & Wilkins
- Mansour AM, "Macular degeneration in angioid streaks", Ophthalmologica, 197, pp.36~41 (1988)
- Singerman LJ, "Laser treatment of choroidal neovascular membranes in angioid streaks", Retina, 1, pp.75~83 (1981)
- Pece A, "Laser photocoagulation of choroidal neovascularization in angioid streaks", Retina, 17, pp.12~16 (1997)
- Lim JI, "Laser treatment of choroidal neovascularization in patients with angioid streaks", Am J Ophthalmol, 116, pp.414~423 (1993)
- Karacorlu M, "Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks", Am J Ophthalmol, 134, pp.360~366 (2002)
- Menchini U, "Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy", Retina, 24, pp.763~771 (2004)
- Mennel S, "Therapeutic strategies in choroidal neovascularizations secondary to angioid streaks", Am J Ophthalmol, 136, pp.580~582 (2003)
- Shaikh S, "Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks", Am J Ophthalmol, 135, pp.1~6 (2003)
- Heimann H, "Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks", Graefes Arch Clin Exp Ophthalmol, 243, pp.1115~1123 (2005)
- Arias L, "Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks", Graefes Arch Clin Exp Ophthalmol, 244, pp.753~757 (2006)
- Rosenfeld PJ, "Optical coherence tomography findings after an intravitreal injection of bevacizumab(avastin)for neovascular age-related macular degeneration", Ophthalmic Surg Lasers Imaging, 36, pp.331~335 (2005)
- Yamamoto I, "Intravitreal bevacizumab(Avastin)as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia", Br J Ophthalmol, 91, pp.157~160 (2007)
- Bhatnagar P, "Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum", Retina, 27, pp.897~902 (2007)
- Rinaldi M, "Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks", Arch Ophthalmol, 125, pp.1422~1423 (2007)
- Wiegand TW, "Intravitreal bevacizumab(Avastin)treatment of choroidal neovascularisation in patients with angioid streaks", Br J Ophthalmol, 93, pp.47~51 (2009)
- Neri P, "Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab(Avastin)", Br J Ophthalmol, 93, pp.155~158 (2009)
- Gomi F, "Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone", Am J Ophthalmol, 143, pp.507~510 (2007)